Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8588096 | e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism | 2011 | 6 Pages |
Abstract
Although bioimpedance spectroscopy estimates of fat-free mass in the end-stage renal disease patient groups were not different from dual-energy X-ray absorptiometry and the methods were highly correlated, there was great individual variability. From these data it is clear that future studies are warranted before bioimpedance spectroscopy can be recommended as a valid clinical tool for assessing fat-free mass in end-stage renal disease patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Sara M. Vine, Patricia L. Painter, Michael A. Kuskowski, Carrie P. Earthman,